MENU
CMMB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Chemomab Therapeutics (CMMB) Earnings Date & Reports

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

CMMB is expected to report earnings to 0 cents per share on May 08

Chemomab Therapeutics CMMB Stock Earnings Reports
Q1'25
Est.
$-0.01
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.03
The last earnings report on March 03 showed earnings per share of 0 cents, beating the estimate of -5 cents. With 195.97K shares outstanding, the current market capitalization sits at 21.31M.
View a ticker or compare two or three
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Kiryat Atidim
Phone
+972 773310156
Employees
20
Web
https://www.chemomab.com